NCT00469274View on ClinicalTrials.gov

Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure

NACompletedINTERVENTIONAL

Enrollment

1,102

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Pertussis

Interventions

DRUG

Antibiotic PEP

Azithromycin 1000mg po x 1, then 500mg po Q day for 4 days; TMP-SMX DS one BID for 14 days

DRUG

Antibiotic PEP

TMP-SMX DS po BID for 14 days

Trial Locations (1)

37232

Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center,, Nashville

All Listed Sponsors

collaborator

Centers for Disease Control and Prevention

FED

lead

Vanderbilt University

OTHER

NCT00469274 - Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure | Biotech Hunter | Biotech Hunter